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Macrophage apoptosis in advanced atheromata,
a key process in plaque necrosis, involves the combi-
nation of ER stress with other proapoptotic stimuli.
We show here that oxidized phospholipids, oxidized
LDL, saturated fatty acids (SFAs), and lipoprotein(a)
trigger apoptosis in ER-stressed macrophages
through a mechanism requiring both CD36 and
Toll-like receptor 2 (TLR2). In vivo, macrophage apo-
ptosis was induced in SFA-fed, ER-stressed wild-
type but notCd36/ or Tlr2/mice. For atheroscle-
rosis, we combined TLR2 deficiency with that of
TLR4, which can also promote apoptosis in ER-
stressed macrophages. Advanced lesions of fat-fed
Ldlr/ mice transplanted with Tlr4/Tlr2/ bone
marrow were markedly protected from macrophage
apoptosis and plaque necrosis compared with
WT/ Ldlr/ lesions. These findings provide insight
into how atherogenic lipoproteins trigger macro-
phage apoptosis in the setting of ER stress and
how TLR activation might promote macrophage
apoptosis and plaque necrosis in advanced athero-
sclerosis.
INTRODUCTION
Atherothrombotic vascular disease is the leading cause of death
in the industrializedworld, and its prevalence is increasingworld-
wide (Braunwald, 1997; Lloyd-Jones et al., 2010). The key clin-
ico-pathologic event is the conversion of a relatively small
percentage of subclinical atherosclerotic lesions to necrotic,Cell Mdisrupted, ‘‘vulnerable’’ plaques that trigger acute lumenal
thrombosis (Libby, 2000; Virmani et al., 2003). Thus, under-
standing the cellular and molecular factors that lead to this
conversion is a key goal in our attempt to understand and iden-
tify potential therapeutic targets for this disease. Importantly,
lesion size per se is not a parameter associated with conversion
(Libby, 2000). Rather, the plaque morphology properties of
intimal necrosis, cellular apoptosis, and fibrous cap thinning
appear to be most important (Libby, 2000; Virmani et al.,
2003). Thus, factors that promote these particular features will
likely give important clues to how plaques progress to the clinical
stage.
Plaque necrosis is a key feature of clinically dangerous lesions
because it promotes inflammation, fibrous cap thinning, plaque
destabilization, and thrombosis (Libby, 2000; Virmani et al.,
2003). Plaque necrosis forms through the combination of lesional
macrophage apoptosis and defective phagocytic clearance
of the apoptotic cells, which leads to postapoptotic cellular
necrosis (Tabas, 2005). Work in our laboratory and others has
provided evidence that advanced lesional macrophage apo-
ptosis is enabled through endoplasmic reticulum (ER) stress,
acting through the unfolded protein response (UPR) effector
CHOP (Feng et al., 2003; Thorp et al., 2009). For example, there
is a close positive correlation among CHOP expression, apo-
ptosis of lesional cells, and progression of plaques to the vulner-
able stage in human coronary arteries (Myoishi et al., 2007), and
studies with CHOP-deficient mice show that CHOP contributes
to advanced lesional apoptosis and plaque necrosis in both
fat-fed Ldlr/ and Apoe/ mice (Thorp et al., 2009).
Although extreme ER stress in vitro can directly cause cell
death, ER stress at the more subtle levels that occur in vivo is
unlikely to trigger apoptosis by itself. Rather, ER stress renders
macrophages susceptible to apoptosis in the face of other proa-
poptotic stimuli (Devries-Seimon et al., 2005; Seimon et al.,
2006; Manning-Tobin et al., 2009). Therefore, understandingetabolism 12, 467–482, November 3, 2010 ª2010 Elsevier Inc. 467
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Figure 1. OxPLs, OxLDL, and Saturated Fatty Acids Induce CD36- and TLR2/6-Dependent Apoptosis in ER-Stressed Macrophages
(A) Macrophages were incubated for 28 hr with 0.25 mM thapsigargin (Tg) alone or thapsigargin in combination with the indicated concentrations of oxLDL.
(B) Macrophages were left untreated (Un) or incubated for 30 hr with 0.25 mM thapsigargin alone or thapsigargin in combination with 10 mg/ml KDdia-PC or
POV-PC or the phospholipids alone.
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CD36-TLR2-Induced Apoptosis in Macrophageswhich athero-relevant stimuli conspire with ER stress to cause
advanced lesional macrophage apoptosis and plaque necrosis
and the mechanism of their action is a key goal in deciphering
the cellular biology of vulnerable plaque formation. In that
context, we show here that a number of lipids and lipoproteins
associated with atherosclerotic disease are potent inducers of
apoptosis in ER-stressed macrophages through a pathway
involving CD36, TLR2, NADPH oxidase, and oxidative stress.
While CD36 and TLRs have been implicated previously in early
atherogenesis, e.g., in foam cell formation and endothelial acti-
vation (Park et al., 2009; Mullick et al., 2008), their role in specific
cellular processes related to the critical and distinct process of
plaque necrosis is not known. Moreover, one of the lipoproteins
that we found to activate the CD36-TLR2 apoptosis pathway is
lipoprotein(a) (Lp(a)). Lp(a) is a well-recognized risk factor for
coronary artery disease (CAD) and has recently been shown to
be strongly linked genetically to CAD (Erqou et al., 2009; Tre´-
goue¨t et al., 2009; Brazier et al., 1999; Holmer et al., 2003), but
how Lp(a) might be linked to one or more cellular events specif-
ically involved in advanced plaque progression is uncertain.
These findings may provide insight into how Lp(a) contributes
to atherothrombotic vascular disease.
RESULTS
Oxidized Phospholipids Trigger CD36-Dependent
Apoptosis in ER-Stressed Macrophages
To discover athero-relevant triggers of apoptosis in ER-stressed
macrophages, we investigated ligands for CD36, which we
recently showed plays a role in plaque necrosis (Manning-Tobin
et al., 2009). To determine whether CD36 ligands trigger macro-
phage apoptosis under conditions of ER stress, we treated
primary mouse peritoneal macrophages with the ER stress-
inducing agent thapsigargin, alone or in the presence of oxLDL,
a CD36 ligand (Endemann et al., 1993). Whereas oxLDL or thap-
sigargin alone had little effect, both reagents together synergis-
tically induced apoptosis (Figure 1A). To test if oxidized phos-
pholipids (oxPLs), which are atherosclerosis-relevant CD36
ligands present in oxLDL, also triggered macrophage apoptosis
during ER stress, we incubated macrophages with two types of
oxPLs found in oxLDL, KDdia-PC and POV-PC (Podrez et al.,
2002). As shown in Figure 1B, while KDdia-PC or POV-PC alone
had no significant effect, they synergistically triggered macro-
phage apoptosis when combined with thapsigargin. Similar
results were observed when ER-stressed macrophages were(C) Macrophages from WT, Sra/, or Cd36/ mice were incubated for 18 hr wi
KDdia-PC or with 50 mg/ml oxLDL.
(D) Macrophages were left untreated or incubated for 23 hr with 50 mg/ml KOdia-P
combination with 0.5 mM thapsigargin (Tg).
(E) Macrophages from WT or Tlr2/mice were incubated for 30 hr with 0.25 mM
or LTA.
(F) Macrophages from WT, Cd36/, or Tlr2/ mice were incubated for 24 hr w
(G) Macrophages from WT, Tlr1/, or Tlr6/ mice were incubated for 24 hr w
Pam2CSK4.
(H) Macrophages from WT, Cd36/, or Tlr2/ mice were incubated for 18 hr
complex with BSA, or thapsigargin plus either the fatty acids or BSA control. T
the saturated fatty acids were stearic acid (18:0) and palmitic acid (16:0). For all e
the data are expressed as the percent of total cells that stained with annexin V
symbols and no symbols or between values with different symbols are statistica
Cell Mincubated with two other oxPLs, KOdia-PC and oxidized PAPC
(below), and apoptosis was also observed when human macro-
phages derived from THP1 cells were exposed to KOdia-PC and
thapsigargin (Figure S1A). OxPL-induced apoptosis in ER-
stressed macrophages was dependent on CD36 but not the
type A scavenger receptor (SRA), as shown by experiments
using macrophages from wild-type (WT), Sra/, and Cd36/
mice (Figure 1C). In a parallel experiment, we found that SRA
deficiency did block apoptosis induced by thapsigargin plus
the SRA ligand AcLDL (data not shown) (Devries-Seimon et al.,
2005).
ER stress and induction of the UPR occurs in macrophages of
atherosclerotic plaques in humans and mice (Feng et al., 2003;
Zhou et al., 2005; Gargalovic et al., 2006; Thorp et al., 2009;
Myoishi et al., 2007). Although the cause of ER stress in vivo is
unknown, substances such as peroxynitrite and 7-ketocholes-
terol have been shown to accumulate in atherosclerotic plaque
and are known inducers of ER stress (Dickhout et al., 2005;
Pedruzzi et al., 2004; Myoishi et al., 2007). We therefore tested
whether oxPLs could trigger apoptosis when combined with
peroxynitrite and 7-ketocholesterol. As shown in Figure S1B,
7-ketocholesterol and SIN-1, a peroxynitrite donor, were poor
inducers of macrophage apoptosis when given at low concen-
trations. However, the addition of KDdia-PC to either of these
ER stress-inducing agents resulted in a marked increase in
macrophage apoptosis. These results indicate that oxPLs can
trigger apoptosis in macrophages exposed to various types of
ER stressors, including those that may be relevant to advanced
atheromata.
CD36-mediated internalization of oxLDL and the bacterial
product LTA are dependent on the molecule dynamin, a GTPase
that mediates the constriction of clathrin-coated pits (Sun et al.,
2007; Nilsen et al., 2008). To test the role of dynamin in CD36-
dependent macrophage apoptosis, macrophages were trans-
duced with adenovirus carrying dominant-negative dynamin
(DN-dyn) or lacZ as a negative control. The effectiveness of
DN-dyn was demonstrated by its ability to block labeled oxLDL
uptake by >90% compared to cells transduced with lacZ control
(data not shown). DN-dyn completely protected macrophages
from apoptosis induced by oxLDL and thapsigargin, KOdia-PC
and thapsigargin, or KOdia-PC and 7-ketocholesterol (Fig-
ure S1C). Note that DN-dyn did not block the small but statisti-
cally significant increase in apoptosis induced by 7-ketocholes-
terol alone, demonstrating that this construct is not a general
inhibitor of apoptosis. These results suggest that CD36 ligandsth thapsigargin alone or thapsigargin in combination with 10 mg/ml POV-PC or
Cwithout (mock) or with (PLA2) pretreatment with phospholipase A2, alone or in
thapsigargin alone or thapsigargin combined with KDdia-PC, POV-PC, oxLDL,
ith thapsigargin alone or thapsigargin combined with 10 mg/ml LTA.
ith thapsigargin with or without KOdia-PC, LTA, or 10 mg/ml Pam3CSK4 or
with 0.25 mM thapsigargin (Tg) alone, 0.25 mM of the indicated fatty acids in
he unsaturated fatty acids were linoleic acid (18:2) and oleic acid (18:1), and
xperiments described, the experimental endpoint was macrophage apoptosis;
and propidium iodide (mean ±SEM; n = 4). Differences between values with
lly significant (p values ranged from <0.05 to <0.001).
etabolism 12, 467–482, November 3, 2010 ª2010 Elsevier Inc. 469
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CD36-TLR2-Induced Apoptosis in Macrophagesmust be internalized, as opposed to functioning solely at the cell
surface, to trigger apoptosis in ER-stressed macrophages.
The Proapoptotic Effect of OxPLs Requires the sn2
Oxidized Fatty Acid
Both the phosphocholine head group and the sn2 fatty acid in
oxPLs are recognized by CD36 (Boullier et al., 2005; Greenberg
et al., 2008). We therefore tested the effect of removing each of
these two groups. Removal of phosphocholine with phospholi-
pase D (PLD), which went to >92% completion as assessed by
HPLC-MS analysis, had no effect on the ability of the oxPL to
induce apoptosis in ER-stressed macrophages (Figures S1D
and S1E). In contrast, treatment of KOdia-PC with phospholi-
pase A2 (PLA2), which cleaves the sn2 fatty acyl moiety of PLs,
almost completely suppressed its ability to trigger apoptosis in
ER-stressed macrophages (Figure 1D). Moreover, whereas
oxidized PAPC induced apoptosis in these cells, nonoxidized
PAPC did not (Figure S1F). These results indicate that the proa-
poptotic effect of oxPLs requires the sn2 oxidized fatty acid and
not the phosphocholine head group.
TLR2 Is Necessary for Apoptosis Induced by CD36
Ligands in ER-Stressed Macrophages
Different classes of pattern recognition receptors can participate
in cooperative interactions, and previous work has shown that
CD36-TLR2 interaction participates in the response to Staphylo-
coccus aureus infection (Stuart et al., 2005; Hoebe et al., 2005).
To test the role of TLR2 in CD36-induced apoptosis in ER-
stressed macrophages, we conducted a series of experiments
comparing macrophages from WT and Tlr2/ mice. As shown
in Figure 1E, TLR2 deficiency markedly protected ER-stressed
macrophages from oxLDL-, POV-PC-, and KDdia-PC-induced
apoptosis. Moreover, lipoteichoic acid (LTA), a staphylococcal
lipid that activates TLR2 in a CD36-dependent manner (Stuart
et al., 2005; Hoebe et al., 2005), also induced apoptosis in
ER-stressed WT macrophages, but not in Tlr2/ or Cd36/
macrophages and not in the absence of ER stress (Figures 1E
and 1F). Tlr4/ macrophages exposed to KDdia-PC, POV-PC,
and oxLDL in combination with thapsigargin showed levels of
apoptosis similar to those of WTmacrophages (data not shown).
These results demonstrate that TLR2, but not TLR4, contributes
to apoptosis induced by CD36 ligands during ER stress.
MyD88 is a signaling adaptor utilized by many of the TLRs and
is considered a primary adaptor for TLR2 (Kenny and O’Neill,
2008). To determine whether apoptosis in the CD36/TLR2/ER
stress model was MyD88 dependent, WT andMyd88/macro-
phages were incubated with the KOdia-PC, a CD36 oxPL ligand
similar to KDdia-PC (Podrez et al., 2002), POV-PC, or LTA in
combination with thapsigargin. As shown in Figure S1G,
apoptosis induced by each of these ligands was markedly sup-
pressed in MyD88-deficient macrophages. In contrast, apo-
ptosis was not blocked in macrophages lacking the other TLR
adaptor, TRIF (data not shown).
TLR2 has been shown to heterodimerize with either TLR1 or
TLR6 to initiate signaling (Pa˚lsson-McDermott and O’Neill,
2007). To determine the possible role of TLR1 and TLR6 in our
model, macrophages from WT, Tlr1/, or Tlr6/ mice were
treated with thapsigargin alone or in combination with KOdia-
PC and LTA (Figure 1G). We found that macrophage apoptosis470 Cell Metabolism 12, 467–482, November 3, 2010 ª2010 Elsevierwas highly dependent on TLR6, but not TLR1.We also compared
the apoptosis-inducing potential of Pam3CSK4, a lipid that has
been reported to be relatively specific for the TLR1/2 hetero-
dimer, with Pam2CSK4, which is reported to activate the
TLR2/6 heterodimer (Pa˚lsson-McDermott and O’Neill, 2007).
As expected, the latter ligand induced apoptosis in ER-stressed
macrophages in a TLR2/6-dependent manner. Unexpectedly,
Pam3CSK4 also induced apoptosis, and its effect was also
blocked in TLR6-deficient but not TLR1-deficient macrophages.
These combined data suggest that the active heterodimer in
the CD36/ER stress apoptosis pathway is TLR2/6.
Saturated Fatty Acids Trigger CD36- and TLR2-
Dependent Apoptosis during ER Stress
Although the sn2 oxidized fatty acid in oxPLs is required for
apoptosis (above), oxPLs and bacterial products such as LTA,
Pam3CSK4, and Pam2CSK4 all have saturated fatty acid resi-
dues at the sn1 and/or sn2 position of the glycerol backbone.
In addition to the role of CD36 in oxLDL uptake and cell signaling,
the receptor also functions as a fatty acid transporter (Ibrahimi
and Abumrad, 2002). Moreover, several studies have suggested
that SFAs might activate TLR2- and TLR4-dependent signaling
(Nguyen et al., 2007; Shi et al., 2006; Senn, 2006; Lee and
Hwang, 2006), although this is not a consistent finding (Erridge
and Samani, 2009). We therefore tested whether different types
of fatty acids could trigger apoptosis in macrophages under-
going ER stress, and if so, whether such an effect was CD36
and/or TLR2 dependent. As shown in Figure 1H, oleic acid and
linoleic acid did not trigger apoptosis when given alone. A small
but significant increase in apoptosis was observed when these
unsaturated fatty acids (UFAs), but not BSA carrier alone, were
combined with thapsigargin. Moreover, this effect was sup-
pressed in macrophages lacking either CD36 or TLR2. When
the SFAs palmitic and stearic acids were given alone, apoptosis
was induced, and this effect was dependent on CD36 but not
TLR2. However, apoptosis by these fatty acids was increased
markedly in the setting of thapsigargin-induced ER stress, and
this increment was dependent on both CD36 and TLR2. Some
studies (Miller et al., 2003; Oka et al., 1998; Hazzard and Ettinger,
1995), though not all (Erridge and Samani, 2009), have sug-
gested that SFAs can also trigger certain TLR4-dependent sig-
naling reactions. We found that palmitic acid-induced apoptosis
was not blocked significantly in TLR4-deficient ER-stressed
macrophages (data not shown). In summary, the combined
CD36/TLR2 pathway of apoptosis plays a role in two scenarios
of fatty acid-induced apoptosis: UFAs in ER-stressed macro-
phages and the increment in SFA-induced apoptosis in ER-
stressed versus non-ER-stressed cells. Finally, we found that
dipalmitoyl PC or dipalmitoyl glycerol, which have SFAs in both
the sn1 and sn2 positions, can trigger apoptosis in ER-stressed
macrophages (data not shown). These findings raise the possi-
bility that SFAs in PLs, in the context of either an sn2 oxidized
fatty acid (above) or sn1 and sn2 SFAs, might play a role in the
apoptotic response in ER-stressed macrophages.
Reactive Oxygen Species Contribute to Macrophage
Apoptosis by CD36 Ligands during ER Stress
Reactive oxygen species (ROS) can contribute to apoptosis
under physiologic and pathologic conditions (Li et al., 2009;Inc.
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Figure 2. CD36 Ligand-Induced Apoptosis in ER-Stressed Macrophages Is Dependent on Reactive Oxygen Species
(A and B) Macrophages were preincubated for 60min in the absence or presence of 100 mMN-acetylcysteine (NAC) and then incubated for 24 hr in medium alone
(Un) or containing 0.25 mM thapsigargin (Tg), 20 mg/ml KDdia-PC, or Tg and KDdia-PC, as indicated. The cells were then assayed for ROS, using the DCF
fluorescence assay, and apoptosis.
(C and D) As above, but here the ER stressor was 5 mg/ml 7-ketocholesterol or 2 mMSIN-1 instead of thapsigargin. Differences between values with symbols and
no symbols or between values with different symbols are statistically significant (p values ranged from <0.05 to <0.01).
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CD36-TLR2-Induced Apoptosis in MacrophagesSimon et al., 2000), and a CD36-ROS pathway has been impli-
cated in oxLDL-induced inactivation of SHP-2 phosphatase in
macrophages (Park et al., 2009). We therefore tested whether
ROS are generated by CD36 ligands during ER stress, and if
so, whether this process plays a role in apoptosis. Treatment
of cells with KDdia-PC, thapsigargin, SIN1, or 7-ketocholesterol
alone resulted in a low level of 20,70-dichlorofluorescin diacetate
(DCF) staining, ameasure of cellular oxidative stress (Frank et al.,
2000) (Figures 2A and 2C). However, when the oxPLs KOdia-PC
or KDdia-PCwere combined with the ER stressors, DCF staining
was substantially increased. Similar results were obtained when
thapsigargin was combined with other TLR2 ligands, including
LTA, Pam2CSK4, and Pam3CSK4 (data not shown). Further-
more, pretreatment of macrophages with the antioxidant N-ace-Cell Mtylcysteine (NAC) suppressed DCF staining and, most impor-
tantly, apoptosis under these conditions (Figures 2B and 2D).
NAC also decreased apoptosis in response to palmitic acid
plus thapsigargin (data not shown). Thus, ROS is an important
component of the CD36/TLR2/ER stress pathway of apoptosis.
Lp(a) Triggers Apoptosis in ER-Stressed Macrophages
in a CD36-TLR2-Oxidative Stress-Dependent Manner
Lp(a) is a modified LDL-like lipoprotein in which a kringle-con-
taining protein called apolipoprotein(a) is covalently bound to
apolipoprotein B of LDL (Koschinsky and Marcovina, 2004).
Epidemiological and human genetic studies have shown that
Lp(a) is a potent, independent risk factor for advanced athero-
thrombotic vascular disease. Moreover, in a transgenic rabbitetabolism 12, 467–482, November 3, 2010 ª2010 Elsevier Inc. 471
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Figure 3. Lp(a) Triggers Apoptosis in ER-Stressed Macrophages in a CD36-TLR2-Oxidative Stress-Dependent Manner
(A and B) Macrophages from WT, Cd36/, Tlr2/, Tlr1/, or Tlr6/ mice were incubated for 24 hr with 0.5 mM thapsigargin alone or in combination with
25 mg/ml LDL or Lp(a), 50 mg/ml KOdia-PC, or 10 mg/ml LTA.
(C) Apoptosis data for macrophages that were preincubated with or without 500 mM N-acetylcysteine (NAC) and then incubated for 24 hr with thapsigargin
alone or with 50 mg/ml of Lp(a).
(D) Macrophages were assayed for apoptosis after incubation for 22 hr with thapsigargin alone or thapsigargin in combination with 25 mg/ml apo(a) that was
pretreated in the absence (mock) or presence of trypsin. The image shows a Coomassie-stained SDS-PAGE of mock and trypsin-treated apo(a); for each
condition, three different amounts of proteins were loaded per lane, increasing from left to right.
(E) As in (D), but here the apo(a) was treated with ±PLA2 prior to trypsinization. *p < 0.01 compared to other groups without the asterisk.
Cell Metabolism
CD36-TLR2-Induced Apoptosis in Macrophagesmodel, modest plasma levels of Lp(a) (15 mg/dl) markedly
promoted plaque necrosis without affecting en face lesion area
(Sun et al., 2002). However, a clear mechanism linking Lp(a)
with a cellular event specifically associated with advanced pla-
que progression has been elusive (Tre´goue¨t et al., 2009; Brazier
et al., 1999; Holmer et al., 2003; Erqou et al., 2009). In the context
of the data herein, a potential clue to this mystery is the recent472 Cell Metabolism 12, 467–482, November 3, 2010 ª2010 Elsevierfinding that Lp(a) is a major carrier of oxPLs in human plasma
(Bergmark et al., 2008). We therefore tested whether Lp(a) could
trigger apoptosis in ER-stressed macrophages (Figure 3A). The
Lp(a) was verified to contain oxPLs by anti-oxPL antibody
(E06) reactivity (data not shown). As expected, neither LDL nor
Lp(a) induced apoptosis when given alone. However, Lp(a)
from two separate subjects, but not LDL, markedly inducedInc.
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CD36-TLR2-Induced Apoptosis in Macrophagesapoptosis when added in combination with thapsigargin. More-
over, apoptosis under these conditions was CD36 dependent.
We then compared Lp(a) with KOdia-PC and LTA in ER-stressed
macrophages fromWT, Tlr2/, Tlr6/, or Tlr1/mice to deter-
mine whether apoptosis induced by Lp(a) was also TLR depen-
dent. As shown in Figure 3B, all ligands triggered apoptosis in
a TLR2- and TLR6-dependent manner. Also similar to oxPL-
induced apoptosis, Lp(a)-induced apoptosis in ER-stressed
macrophages could be suppressed by NAC (Figure 3C).
The oxPLs of Lp(a) are found both in the lipid phase and cova-
lently bound to apo(a) (Bergmark et al., 2008; Edelstein et al.,
2003). The next series of studies was conducted using recombi-
nant 17-kringle apo(a) (Feric et al., 2008), which contains oxPLs
as assessed by both anti-oxPL antibody (E06) reactivity and
mass spectrometry (data not shown). These oxPLs are presum-
ably acquired during secretion from the protein-producing cells.
We found that apo(a) was a potent inducer of apoptosis in
ER-stressed macrophages (Figure 3D). To determine whether
apoptosis depended on an intact apo(a) protein, apo(a) was sub-
jected to digestion with trypsin or mock treatment in buffer alone.
Trypsin treatment led to extensive digestion of apo(a), which nor-
mally migrates between 250 and 500 kDa, depending on the
level of glycosylation (Koschinsky et al., 1991) (Figure 3D, gel
image). The apoptosis data in Figure 3D show that the trypsin-
treated protein had the same level of proapoptotic activity as
the mock-treated protein, consistent with a role for apo(a)-asso-
ciated lipids.
To gain further evidence that oxPLs on apo(a) are necessary
for its proapoptotic activity, the apo(a) preparation was treated
with PLA2 or buffer alone (mock). Because oxPLs are bound
covalently to apo(a) through the sn2 oxidized fatty acyl moiety
(Edelstein et al., 2003), PLA2 hydrolysis would be expected to
release the lipids from the protein as lysoPC. After treatment,
the apo(a)-PLA2 (or mock) reaction mixture was subjected to
trypsin treatment to avoid an effect of the PLA2 on the cells. As
shown in Figure 3E, PLA2 treatment completely abrogated apo
(a)-induced apoptosis in ER-stressed macrophages, further
supporting a role for apo(a)-associated phospholipids in the
apoptotic response. In summary, oxPL-containing Lp(a) and
apo(a) are potent inducers of macrophage apoptosis in the
setting of ER stress. The mechanism, like that of oxPL, involves
CD36, TLR2, TLR6, and oxidative stress in the macrophages.
NOX2 Is Necessary for the Generation of ROS
and Apoptosis by CD36 Ligands during ER Stress
To determinewhether NADPH oxidase could be a source of ROS
and involved in apoptosis in ER-stressedmacrophages exposed
to CD36 ligands, we comparedmacrophages fromWTmice with
those from mice lacking TLR2, CD36, or the macrophage
NADPH oxidase subunit NOX2. Time course analysis revealed
that DCF staining increased after 1 hr of KDdia-PC/thapsigargin
treatment, peaked at 4 hr, dropped slightly between 4 and 8 hr,
and then remained at this level for the next 16 hr (Figure 4A).
However, NOX2-, TLR2-, and CD36-deficient macrophages
showed suppressed DCF staining throughout the entire time
course. Most importantly, apoptosis was suppressed in NOX2-
deficient macrophages treated with palmitic acid, KOdia-PC,
or LTA in combination with thapsigargin (Figure 4B). Similar
results were found when the combination of KOdia-PC andCell Meither 7-ketocholesterol or SIN-1 was used (data not shown).
Thus, CD36 ligands promote ROS accumulation in ER-stressed
macrophages in a CD36-, TLR2-, and NOX2-dependent manner,
and both ROS and NOX2 are necessary for the full apoptotic
response in this setting.
During NADPH oxidase activation, p47phox is recruited to
membranes as part of the assembly of the NADPH oxidase
complex. This process causes ‘‘clustering’’ of p47 at the plasma
membrane or endocytic/phagocytic compartment (Laroux et al.,
2005). While p47phox is localized diffusely in unstimulated
cells, treatment with KOdia-PC for 4 hr led to an increase of
p47phox clustering (Figure 4C). Interestingly, p47 appeared to
cluster in regions that stained with LysoTracker Green, suggest-
ing assembly on acidic organelles such as lysosomes. After
8 hr, the percentage of cells exhibiting p47phox clustering in
response to KOdia-PC alone dropped significantly (Figure 4D).
Cells treated with KOdia-PC in combination with thapsigargin
also exhibited an increase in p47phox clustering, but in this
case clustering was sustained and did not diminish by 8 hr. The
combination of KOdia-PC with SIN-1 or 7-ketocholesterol also
led to sustained clustering of p47phox (data not shown). Thapsi-
gargin alone did not induce p47phox clustering at any of the time
points examined. As a positive control, macrophages were
treated for30minwith500ng/mlLPS to induceclustering (Figures
4C and 4D). Thus, while KOdia-PC alone induces transient clus-
tering of p47phox within acidic compartments, the addition of
an ER stressor causes sustained p47phox clustering, consistent
with sustained ROS production under these conditions.
TLR2-Dependent ERK Activation Is Necessary
for Apoptosis, p47phox Clustering, and ROS Production
Several kinases, such as PKC, ERK, and c-Src, have been impli-
cated in promoting p47 phosphorylation and NADPH oxidase
activation (Dewas et al., 2000; Touyz et al., 2003; Bey et al.,
2004). We therefore screened a variety of inhibitors for their
ability to suppress apoptosis in ER-stressed macrophages
exposed to CD36 ligands. We found that the conventional
PKC inhibitor Go6976, the pan-PKC inhibitor Go6983, and the
Src inhibitor PP2 had no effect on apoptosis. In contrast,
PD98058, which inhibits MEK1 and its downstream substrate
ERK, completely suppressed apoptosis induced by KOdia-PC
or LTA in combination with thapsigargin (Figure 5A). Although
ERK has been shown to promote cell survival in other models
of ER stress (Hu et al., 2004), these data and others (Sim et al.,
2005) suggest that ERK can mediate apoptosis in ER-stressed
macrophages exposed to CD36 ligands. To directly demonstrate
the concept of context-dependent effects of ERK inhibition, we
treated macrophages with a dose of 7-ketocholesterol that
induces apoptosis in the absence of a CD36 ligand (Figure 5A).
We found that macrophages treated with the ERK inhibitor
were markedly more susceptible to apoptosis in this scenario,
demonstrating that ERK functions as a survival kinase in an ER
stress model that does not involve CD36.
To determine whether ERK plays a role in NADPH oxidase
activation and ROS production, macrophages were exposed
to KOdia-PC or LTA in combination with thapsigargin, with or
without treatment with PD98058. The ERK inhibitor markedly
suppressed DCF staining induced by KOdia-PC or LTA
during ER stress (Figure 5B). Similar results were found whenetabolism 12, 467–482, November 3, 2010 ª2010 Elsevier Inc. 473
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Figure 4. Sustained Activation of NADPH Oxidase by CD36 Ligands in ER-Stressed Macrophages
(A) Macrophages fromWT, Cd36/,Nox2/, or Tlr2/mice were incubated for the indicated times with 0.25 mM thapsigargin (Tg) alone or in combination with
20 mg/ml POV-PC and then assayed for the percent of DCF-positive cells (ROS).
(B) Macrophages fromWT orNox2/mice were incubated for 24 hr with thapsigargin alone or in combination with KOdia-PC, 10 mg/ml LTA, or 0.25mM palmitic
acid (PA). The cells were then assayed for apoptosis.
(C) Macrophages were incubated for 4 hr in medium alone or medium containing KOdia-PC, thapsigargin, or the two reagents combined and then subjected to
immunofluorescence for p47phox (red) and labelingwith LysoTrackerGreen and the nuclear stain DAPI (blue). Treatment with LPS for 30minwas used as a positive
control. Bar, 5 mm.
(D) Quantification of the data at two time points for the experiment in (C), expressed as the percent of total cells that exhibited p47 clustering (mean ±SEM, n = 4).
Differences between values with symbols and no symbols or between values with different symbols are statistically significant (p < 0.05).
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CD36-TLR2-Induced Apoptosis in Macrophagesp47phox clustering was assayed (Figure 5C). Moreover, KDdia-
PC promoted ERK phosphorylation, a measure of its activation,
in two phases, peaking at 30 min and 18–24 hr, respectively
(Figure 5D). The latter phase was partially dependent on TLR2,
but not on NOX2 (Figures 5D and 5E). Taken together, these
results are consistent with a model in which ERK is activated
downstream of TLR2, leading to p47 translocation and NADPH
oxidase activation.
SFAs Trigger CD36 and TLR2-Dependent Apoptosis
in Macrophages Undergoing ER Stress In Vivo
To test the relevance of the CD36-ER stress apoptosis pathway
in vivo, we compared chow-fed mice with mice fed a diet con-474 Cell Metabolism 12, 467–482, November 3, 2010 ª2010 Elseviertaining 3.3% cocoa butter, which is rich in stearic and palmitic
acids. After 2 weeks on the diet, the mice were given an intraper-
itoneal (i.p.) injection of concanavalin A to recruit macrophages
to the peritoneal cavity. Two days later, the mice were given
another i.p. injection of 0.4 mg/kg of thapsigargin dissolved in
150 mM dextrose or, as a control, dextrose vehicle alone. After
24 hr, freshly isolated peritoneal macrophages were assayed
for apoptosis. As shown in Figure 6A, macrophages from mice
fed the SFA diet and subsequently given vehicle control had
very little apoptosis. Similar results were seen when mice were
fed a regular chow diet for 2 weeks, followed by an i.p. injection
of thapsigargin. In contrast, there was a marked increase in
apoptosis in macrophages isolated from mice fed the SFA dietInc.
0 .25 1.5 .75 2 3
WT Mφs
0 .25 1.5 .75 2 3   hr KDdia-PC
Tlr2-/- Mφs
4 5 186 8 24 30 4 5 186 8 24 30  hr KDdia-PC
P-ERK
ERK
ERK
P-ERK
D
0
5
10
15
20
25
30
U
n
T
g
 +
 K
O
d
ia
-P
C
T
g
 +
 K
O
d
ia
-P
C
 +
 G
o
6
9
8
3
T
g
 +
 K
O
d
ia
-P
C
 +
 G
o
6
9
7
6
T
g
 +
 K
O
d
ia
-P
C
 +
 P
P
2
T
g
 +
 K
O
d
ia
-P
C
 +
 P
D
9
8
0
5
9
T
g
 +
 L
T
A
T
g
 +
 L
T
A
 +
 P
D
9
8
0
5
9
7
-K
C
7
-K
C
 +
 P
D
9
8
0
5
9
%
 A
po
pt
ot
ic 
ce
lls
A
**
*
*
*
*
*
***
B
*
0
2
4
6
8
10
12
14
16
18
U
n
T
g
 +
 K
O
d
ia
-P
C
T
g
 +
 K
O
d
ia
-P
C
 +
 P
D
9
8
0
5
9
T
g
 +
 L
T
A
T
g
 +
 L
T
A
 +
 P
D
9
8
0
5
9
%
 D
CF
DA
 p
os
itiv
e 
ce
lls
0
5
10
15
20
25
U
n
T
g
 +
 K
O
d
ia
-P
C
T
g
 +
 K
O
d
ia
-P
C
 +
 P
D
9
8
0
5
9
T
g
 +
 L
T
A
T
g
 +
 L
T
A
 +
 P
D
9
8
0
5
9
%
 C
el
ls 
wi
th
 p
47
 c
lu
st
er
in
g
C
*
*
*
E
0 .25 1.5 .75 2 3
WT Mφs
0 .25 1.5 .75 2 3   hr KDdia-PC
Nox2-/- Mφs
4 5 186 8 24 30 4 5 186 8 24 30  hr KDdia-PC
ERK
P-ERK
ERK
P-ERK
Figure 5. TLR2-Dependent ERK Activation Promotes Apoptosis, ROS Generation, and p47phox Clustering
(A–C)Macrophageswere left untreated (Un) or incubated for 24 hr with the ER stressors thapsigargin or 7-ketocholesterol, alone or in combination with KOdia-PC
or LTA. Some of the samples were pretreated for 1 hr with 250 nM of the conventional or pan-PKC inhibitors Go6976 and Go6983, respectively, 10 mMof the Src-
like kinase inhibitor PP2, or 10 mM of the MEK1 inhibitor PD98059. The cells were then analyzed for apoptosis (A), DCF positivity (B), or p47phox clustering (C).
(D and E) Macrophages fromWT,Nox2/, or Tlr2/mice were incubated with KDdia-PC alone for the indicated times. Cell lysates were then immunoblotted for
Thr202/Tyr204-phospho-ERK1/2 and total ERK. Differences between values with symbols and no symbols or between values with different symbols are statis-
tically significant (p < 0.05).
Cell Metabolism
CD36-TLR2-Induced Apoptosis in Macrophagesin combination with thapsigargin. Although SFAs can induce ER
stress under certain conditions (Borradaile et al., 2006; Erbay
et al., 2009), we found that proapoptotic CHOP was not inducedCell Min macrophages from the SFA-fed mice and was not increased
above the thapsigargin-alone level in macrophages from SFA/
thapsigargin-treated mice (data not shown). Using the TUNELetabolism 12, 467–482, November 3, 2010 ª2010 Elsevier Inc. 475
02
4
6
8
10
12
14
16
18
20
*
%
 
A
p
o
p
t
o
s
is
 
o
f
 
M
a
c
3
-
p
o
s
i
t
i
v
e
 s
p
le
e
n
 c
e
l
ls
WT Tlr2-/-
0
2
4
6
8
10
12
14
16
18
20
F
ob/ob mice
*
%
 
A
p
o
p
t
o
s
is
 
o
f
p
e
r
i
t
o
n
e
a
l
 
M
φs
0
1
2
3
4
5
6
7
8
9
10
UFA diet
SFA diet
Chow
Tg
%
 
A
p
o
p
t
o
s
is
 
o
f
p
e
r
i
t
o
n
e
a
l
 
M
φs
A
B SFA +
Vehicle (i.p.)
SFA + 
Tg (i.p.)
Chow +
Tg (i.p.)
Mac3/TUNEL
SFA +
Vehicle (i.p.)
SFA + 
Tg (i.p.)
Chow +
Tg (i.p.)
*
%
 
A
p
o
p
t
o
s
is
 
o
f
 
M
a
c
3
-
p
o
s
i
t
i
v
e
 s
p
le
e
n
 c
e
l
ls
*
SFA
Veh
SFA
Tg
0
1
2
3
4
5
6
7
8
9
10
11
12
SFA + Veh
SFA + Tg
Chow + Tg
%
 
A
p
o
p
t
o
s
is
 
o
f
p
e
r
i
t
o
n
e
a
l
 
M
φs
SFA + Tg (i.p.)
*
0
1
2
3
4
5
6
7
8
WT
Tlr2 -/-
WT Cd36-/-
*
0
2
4
6
8
10
12
%
 
A
p
o
p
t
o
s
is
 
o
f
 
M
a
c
3
-
p
o
s
i
t
i
v
e
 s
p
le
e
n
 c
e
l
ls
E
*
SFA + Tg (i.p.)
0
1
2
3
4
5
6
7
8
WT
Cd36 -/-
%
 
A
p
o
p
t
o
s
is
 
o
f
p
e
r
i
t
o
n
e
a
l
 
M
φ s
D
C
G
Figure 6. SFAs Trigger CD36- and TLR2-Dependent Macrophage Apoptosis In Vivo
(A and B) Mice were fed a regular chow diet or a diet containing saturated fatty acids (SFAs) for 2 weeks. Concanavalin A was administered i.p., and 2 days later
the mice were given an i.p. injection of 150 mM dextrose (vehicle) or 0.4 mg/kg thapsigargin (Tg) in dextrose. Macrophages were harvested from the peritoneum
24 hr later and stained immediately with Alexa 488 annexin V and propidium iodide (A). Representative fluorescent and bright-field images are shown. Bar, 20 mm.
The dot plot shows the quantified data for each individual mouse, whichwas obtained from five individual fields/mouse. The horizontal line represents themean in
each group (*p < 0.05). Spleens harvested from these mice were sectioned and stained for the macrophage marker Mac3 (green) and for apoptosis by TUNEL
(red) (B) (bar, 10 mm; *p < 0.05).
(C–F) WT, Cd36/, and Tlr2/ mice were fed a SFA-rich diet for 2 weeks and then treated with thapsigargin as described above. Peritoneal macrophages
(C and D) and splenic macrophages (E and F) were then assayed for apoptosis.
(G) ob/ob mice were fed a diet rich in SFAs or unsaturated fatty acids (UFAs) for 2 weeks, and then freshly isolated peritoneal macrophages were assayed for
apoptosis. The horizontal lines in (C), (D), and (G) represent the mean value in each group (*p < 0.05).
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CD36-TLR2-Induced Apoptosis in Macrophagesassay, apoptosis was also quantified in splenic macrophages
from the same groups of mice. As shown in Figure 6B, a marked
increase in apoptosis of Mac3-positive splenic macrophages
was observed in ER-stressed mice fed the SFA diet but not in
those fed the chow diet.
To determine whether the increase in apoptosis observed
in vivo was dependent on CD36 and/or TLR2, WT, Cd36/,
and Tlr2/ mice were compared in the above experimental
protocol. Peritoneal and splenic macrophages were protected
from apoptosis in both CD36-deficient and TLR2-deficient
mice (Figures 6C–6F). To test SFA-induced apoptosis in a phys-
iologic model of ER stress, we used the leptin-deficient ob/ob
model, a model of ER stress and insulin resistance whose
macrophages undergo a low level of ER stress in vivo (C.-P.
Liang, S. Han, G. Li, T. Senokuchi, I.T., and A.R. Tall, unpublished
data) (Li et al., 2009). Apoptosis in peritoneal cavity macro-
phages was determined in ob/ob mice fed either the aforemen-
tioned SFA diet or a calorically matched safflower oil diet rich in
the UFAs, which are relatively weak inducers of apoptosis (see
Figure 1H). SFA- and UFA-treated mice had similar weights
and plasma glucose and insulin levels, and the macrophages
harvested from the two groups of mice showed similar induction
of iNOS by LPS (data not shown). As shown in Figure 6G,
apoptosis was significantly higher in the ob/ob mice fed the
SFA diet. Thus, the level of ER stress that occurs in ob/ob
mice is enough to trigger SFA-induced macrophage apoptosis
in the absence of an exogenous ER stressor.
TLR2/4 Deficiency Suppresses Advanced Lesional
Macrophage Apoptosis and Plaque Necrosis
in Ldlr–/– Mice
We have previously shown that Apoe/ mice with a combined
deficiency of SRA and CD36 are protected from advanced
lesional macrophage apoptosis and plaque necrosis (Manning-
Tobin et al., 2009). Importantly, plaque necrosis was not
decreased in atherosclerosis models with deficiencies of SRA
alone or CD36 alone (T.A.S., K.J.M., and I.T., unpublished
data), indicating that both pathways of apoptosis need to
be eliminated before effects are observed. Because fat-fed
Ldlr /mice transplanted with bonemarrow frommice deficient
in TLR4 alone also did not demonstrate an effect on advanced
plaques (T.A.S. and I.T., unpublished data), and because CD36
requires TLR2 while SRA requires TLR4 (Seimon et al., 2006),
we determined whether combined deficiency of TLR2 and
TLR4 suppresses advanced lesional macrophage apoptosis in
a mouse model of atherosclerosis. Note that while a number of
studies have shown roles for TLR2 and TLR4 in early athero-
genesis (Michelsen et al., 2004; Mullick et al., 2008), their
involvement in the key process of advanced plaque progression,
specifically plaque necrosis, has not been examined. Thus,
Ldlr/ mice were reconstituted with WT or Tlr2/Tlr4/ bone
marrow and then placed on a western-type diet for 10 weeks.
The two groups of mice showed no statistically significant differ-
ence in body weight (data not shown); total plasma cholesterol,
HDL, and triglycerides; or FPLC lipoprotein profile (Figure 7A).
Aortic root lesion area, which would not necessarily be altered
by procepsses affecting advanced lesional macrophage apo-
ptosis, was modestly decreased in the TLR2/4-deficient group,
but the difference was not statistically significant (Figure 7B).Cell MIn contrast, there was a statistically significant 45% decrease
in percent necrotic area in the Tlr2/Tlr4// Ldlr/ lesions.
Plaque necrosis arises as a consequence of advanced lesion
macrophage apoptosis (Tabas, 2005; Schrijvers et al., 2007).
We therefore assessed the effect of TLR2/TLR4 deficiency on
lesional macrophage apoptosis using TUNEL and activated cas-
pase-3 staining. As shown in Figures 7C and 7D, there was an
approximately 60% decrease in TUNEL positivity and a 75%
decrease in activated caspase-3 staining in Tlr2/Tlr4/ /
Ldlr/ lesions. Themajority of the TUNEL-positive cells colocal-
ized with the macrophage marker Mac3, as assessed by immu-
nofluorescence microscopy (Figure S2). Thus, combined TLR2
and TLR4 deficiency in bone-marrow-derived cells of Ldlr/
mice is partially protective against macrophage apoptosis and
plaque necrosis in advanced atherosclerosis.
DISCUSSION
The vast majority of atherosclerotic lesions, even those that are
relatively large, are clinically silent (Libby, 2000). Rather, acute
atherothrombotic vascular disease, the leading cause of death
in the industrialized world, is caused by a very small minority of
lesions that are characterized not by large lesion volume but
by plaque necrosis, plaque disruption, and susceptibility to
acute thrombosis (Libby, 2000; Virmani et al., 2003). This report
provides evidence in vitro and in vivo that a pathway involving
the pattern recognition receptors CD36 and TLR2/6 plays an
important role in a critical process leading to plaque necrosis,
namely, the triggering of apoptosis in ER-stressedmacrophages
(Figure S3). Although these pattern recognition receptors have
been implicated previously in very different processes related
to early atherogenesis (below), their role in the late lesional event
of apoptosis in ER-stressed macrophages provides a link from
these receptors to the completely distinct and clinically relevant
process of plaque necrosis. Moreover, these studies have
revealed the surprising and fascinating finding that Lp(a), a
oxPL-carrying lipoprotein specifically associated with acute
atherothrombosis through an unknown mechanism, is a potent
stimulator of this CD36-TLR2 apoptosis pathway in ER-stressed
macrophages.
While this is the first study to examine the role of CD36 and
TLR2 in processes related specifically to plaque necrosis, other
studies have examined their roles in early atherogenesis. For
example, several studies have shown that SRA and/or CD36
deficiency protects mice from macrophage foam cell formation
in mouse models of atherosclerosis, although the magnitude of
this effect can be quite modest and shows dependence on the
level of oxLDL-associated CD36 ligands induced by certain diets
(Silverstein, 2009; Zhao et al., 2005; Manning-Tobin et al., 2009;
Kennedy et al., 2009). CD36 has also been implicated in macro-
phage trapping in lesions (Park et al., 2009). Similarly, a number
of previous studies have examined the role of TLR2 on athero-
genic processes relevant mostly to early lesion development
(Mullick et al., 2005, 2008; Liu et al., 2008). These studies have
revealed that endogenous TLR2 ligands may be acting primarily
on endothelial cells, while exogenous ligands exert their effect
on macrophages (Mullick et al., 2005). Of interest, one study
linked TLR2 to activation of NF-kB and the induction of inflam-
matory cytokines and matrix metalloproteases (MMPs) in mixedetabolism 12, 467–482, November 3, 2010 ª2010 Elsevier Inc. 477
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Figure 7. TLR2/4 Deficiency in Bone-Marrow-Derived Cells Suppresses Apoptosis and Plaque Necrosis in Advanced Aortic Root Lesions
of Fat-Fed Ldlr–/– Mice
(A) Ldlr/ mice were transplanted with Tlr2+/+Tlr4+/+ (WT) or Tlr2/Tlr4/ bone marrow and then fed a western-type diet for 10 weeks starting 4 weeks after
transplantation. Plasma cholesterol, triacylglycerol, HDL, and FPLC lipoprotein profiles of the two groups of mice are shown in (A). There were no statistical differ-
ences between the two groups in any of the values.
(B–D) Images and quantification of lesion area and percent necrotic area (n = 10 and n = 9), percent of TUNEL-positive cells (n = 10 and n = 7), and percent acti-
vated caspase-3-positive cells (n = 8 and n = 9) in the lesions of Ldlr/ mice transplanted with bone marrow from WT and Tlr4/Tlr2/ mice, respectively.
Hematoxylin and eosin staining of the sections is shown in (B) with the necrotic area outlined (dotted black lines), and (C) shows TUNEL (red) and DAPI (blue)
staining. The p values shown in (B)–(D) were derived from the Mann-Whitney test. Bars in (B) and (C), 20 and 15 mm, respectively.
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mens (Monaco et al., 2009). If future in vivo studies provide
evidence for TLR2-induced inflammation and MMP induction
in advanced lesions in vivo, these actions of TLR2 would
complement the proapoptotic role for TLR2 revealed here in
terms of advanced plaque progression.
The identity of the molecular components on oxPLs, including
oxPLs associated with Lp(a)/apo(a), that activate the CD36-
TLR2/6 pathway remains to be fully elucidated. Our data thus
far suggest that with free oxPLs, the sn2 oxidized fatty acid is
a required element, but in view of our data showing that free
SFAs and dipalmitoyl PC can trigger the pathway, it may work
in concert with the sn1 SFA of oxPLs. However, the situation
with the oxPLs associated with apo(a) is likely to be different if
the sn2 oxidized fatty acid is covalently bound to the protein,
as suggested by previous work (Edelstein et al., 2003; Bergmark
et al., 2008). In this case, the sn1 SFA may play a critical role,
perhaps in concert with the phosphocholine head group.
Another area for future investigation is to determine why oxPL
internalization is necessary to trigger apoptosis in ER-stressed
macrophages (Figure S5) and how this process might work
in concert with cell-surface signaling through CD36 and/or
TLR2/6 heterodimer.
The role of SFAs in the apoptosis pathway described here is
an important finding both mechanistically and because of its
potential relevance to obesity and insulin resistance. SFAs
have been reported to directly stimulate TLR signaling (Shi
et al., 2006; Senn, 2006; Nguyen et al., 2007), but these findings
have recently been challenged by a study showing LPS contam-
ination in the BSA used to complex the SFAs (Erridge and
Samani, 2009). Contamination of BSA with TLR activators
cannot account for the ability of SFAs to trigger apoptosis in
ER-stressed macrophages, because LPS in our model does
not serve as a second TLR hit for apoptosis in ER-stressed
macrophages (Seimon et al., 2006), and the proapoptotic effect
of fatty acids in the current study was TLR4 independent. More-
over, the SFA-free BSA control did not trigger macrophage
apoptosis when combined with thapsigargin, and SFAs were
much more potent in inducing apoptosis than unsaturated FAs,
which were also complexed with BSA. In addition to activating
TLRs, SFAs can directly trigger proapoptotic ER stress (Wei
et al., 2006), which likely accounts for the residual level of
TLR2-independent macrophage death we observed with SFAs
in the absence of thapsigargin (Figure 1H). In this regard, a recent
study showed that SFAs at a dose of 500 mMalone can cause ER
stress-induced macrophage death through a pathway mediated
by adipocyte-binding protein-4 (aP2), a cytosolic lipid chaperone
that is also expressed in macrophages (Erbay et al., 2009).
However, our in vivo studies with ob/ob and Ldlr/ mice
suggest that the TLR-dependent pathway of macrophage death
revealed herein is relevant to pathological settings in which ER
stress is present.
As mentioned above, our study may provide insight into how
Lp(a) contributes to atherothrombotic vascular disease. Lp(a) is
an independent risk factor for CAD, but the mechanism under-
lying this observation is not known (Tre´goue¨t et al., 2009; Brazier
et al., 1999; Holmer et al., 2003; Bergmark et al., 2008; Erqou
et al., 2009). Recent insight was provided by the finding that
Lp(a) functions as a carrier of PC-containing oxPLs (BergmarkCell Met al., 2008), and we show here that oxPL-containing Lp(a) and
apo(a) can trigger apoptosis in ER-stressed macrophages in
a CD36-, TLR2/6-, ROS-, and sn2 fatty acid-dependent manner.
These findings may explain a report in 1994 showing that Lp(a)
can induce oxidative stress in monocytes (Riis Hansen et al.,
1994), although no mechanism was reported. Relevant to a
role for Lp(a) in ER stress-inducedmacrophage apoptosis, trans-
genic hyperlipidemic rabbits with modest plasma levels of Lp(a)
have a marked increase in plaque necrosis without a change in
plasma lipids or en face lesion area compared with nontrans-
genic WHHL rabbits (Sun et al., 2002). This finding is consistent
with the association between high plasma levels of Lp(a) and
acute coronary syndromes. Thus, our findings raise the possi-
bility of a specific cellular mechanism linking elevated plasma
Lp(a) to advanced plaque progression and consequent athero-
thrombotic vascular disease.
The ultimate goal of studies on advanced plaque progression
in general and advanced lesional macrophage apoptosis in
particular is to suggest therapeutic strategies that specifically
block the progression of the 2%–3% of total human atheroscle-
rotic lesions that actually cause acute atherothrombotic vascular
disease. If one were to focus on interrupting the proximal com-
ponents of the pathway described herein, i.e., CD36 or TLR2,
lesional targeting would likely be required for specificity in view
of the widespread role of these receptors in normal physiology
and host defense. A further therapeutic clue from the data herein
may come from the critical role of prolonged oxidative stress.
On the one hand, we show here that ER stress is needed for
prolongation of this response per se, and recent work using
chemical chaperones to suppress ER stress has suggested
potential promise of this approach in the setting of atheroscle-
rosis (Erbay et al., 2009). The initial oxidant burst itself, which
is triggered by a TLR2-NADPH oxidase pathway, is also a
possible target through NADPH oxidase inhibitors (Yu et al.,
2008) or antioxidants that partially suppress the response but
do not compromise its role in host defense. The fact that vitamin
E is not useful in preventing human cardiovascular disease may
be due to the fact that it does not adequately target the specific
types and mechanisms of oxidative stress that are key to plaque
progression (Williams and Fisher, 2005). Indeed, the protective
actions of NAC in our cell culture model of ER stress-induced
macrophage apoptosis were not found with doses of vitamin E
that have antioxidant actions in other settings (G. Li and I.T.,
unpublished data). Of interest in this regard, NAC has been
shown recently to suppress atherosclerosis in fat-fed Apoe/
mice (Shimada et al., 2009). These types of findings and thera-
peutic strategizing provide strong rationale for understanding
in depth the cellular and molecular mechanisms that specifically
promote advanced plaque progression.EXPERIMENTAL PROCEDURES
Animals and Diets
The following mice were purchased from Jackson Laboratory (Bar Harbor,
ME): C57BL/6J, Tlr2/ (strain B6.129 Tlr2 tm1Kir/J) backcrossed to the
C57BL/6J background, TLR4-deficient (strain C57BL/10ScNJ), Nox2/
(strain B6.129S6-Cybbtm1Din/J), Ldlr/ (B6.129S7-Ldlrtm1Her/J), and ob/ob
(B6.V-Lepob/J). The Myd88/, Sra/ (Msr/)Cd36/, Tlr4/, Tlr1/, and
Tlr6/ mice were generated as described previously (Seimon et al., 2006;
Moore et al., 2005; Adachi et al., 1998; Hoshino et al., 1999; Takeuchi et al.,etabolism 12, 467–482, November 3, 2010 ª2010 Elsevier Inc. 479
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to generate Tlr2/Tlr4/ mice as donors. Macrophages from female 8- to
10-week-old C57BL/6J mice were used as WT controls in all experiments.
The SFA andUFA diets were purchased fromResearchDiets, Inc. (NewBruns-
wick, NJ). Both the SFA diet (formula #D06040503) and UFA diet (formula
#D09021101) were matched for caloric content and contain 20% protein
and 70% carbohydrate. The SFA diet contains 3.5% cocoa butter (43% pal-
mitic and stearic acids, 40% oleic and linoleic acids). The UFA diet contains
3.5% safflower oil (10% palmitic and stearic acids, 76% oleic and linoleic
acids). For the atherosclerosis study, male mice at 14 weeks of age and
4 weeks after the bone marrow transplant were placed on a western-type
diet (TD88137, Harlan Teklad; Madison, WI) for 10 weeks.
Bone Marrow Transplantation
Ten-week-old male Ldlr/ mice were lethally irradiated using a cesium g
source at a dose of 1000 rad 4–6 hr before transplantation. Bone marrow cells
were collected from the femurs and tibias of donor WT and Tlr2/Tlr4/mice
by flushing with sterile medium as described previously (Lim et al., 2008). All
animal procedures used in this study followed Columbia University’s institu-
tional guidelines.
Macrophage Staining ofMouse Spleen Sections andAtherosclerotic
Lesions
Specimens were immersion-fixed in 10% neutral-buffered formalin (for
spleens) or 1% paraformaldehyde in PBS (for hearts) overnight, followed by
paraffin embedding. Sections (7 mM) on glass slides were deparaffinized in
xylene and hydrated in water. Antigen retrieval was obtained by exposing
the slides to 1 mM EDTA (pH 8) in a steamer for 20 min. The sections were per-
meabilized with 0.1% Triton X-100 and then incubated with anti-Mac3 anti-
body overnight, followed by incubation with a biotinylated anti-rat IgG and
then streptavidin-conjugated Alexa 488-labeled antibody. Sections were
stained for TUNEL as described below, followed by counterstaining with
DAPI to identify nuclei.
Apoptosis Assays
Apoptosis was assayed in cultured macrophages by staining with Alexa 488-
conjugated annexin V (green) and propidium iodide (PI, red) as described
previously (Devries-Seimon et al., 2005). Apoptotic cells in tissues were
labeled by TUNEL using the In Situ Cell Death Detection Kit TMR red (Roche
Diagnostics) according to the manufacturer’s protocol. Only TUNEL-positive
cells that colocalized with DAPI-stained nuclei and Mac3 were counted as
being positive. TUNEL and annexin staining were viewed using an Olympus
IX70 inverted fluorescent microscope. Representative fields (4–6 fields con-
taining 1000 cells) were photographed using an Olympus DP71 CCD
camera. The number of annexin V- and PI-positive cells was counted and ex-
pressed as a percent of the total number of cells in at least four separate fields
from duplicate wells. For TUNEL analysis, DAPI, TUNEL, and/or Mac3 images
were merged using Photoshop analysis software (Adobe Systems). The
number of cells positive for TUNEL, DAPI, and Mac3 (in spleen sections
only) was counted in two fields from each mouse and expressed as the
percentage of total Mac3-positive cells in the image. Activated caspase-3
staining was performed using the SignalStain Cleaved Caspase-3 (Asp175)
IHC detection kit according to the manufacturer’s protocol (Cell Signaling
Technology; Danvers, MA).
p47phox Clustering Assay
Macrophages were plated at 50% confluency and treated the following day, as
indicated in the figure legends. The media were removed, and the cells were
incubated for 10 min at 37C with 50 nM LysoTracker Green DND25 in PBS.
The cells were then rinsed with PBS twice, fixed in 4% paraformaldehyde in
PBS for 20 min, rinsed again, and permeabilized using 0.5% Triton X-100 in
PBS for 5min. The permeabilized cells were incubated for 60min in 5% normal
goat serum and then overnight at 4C with a rabbit anti-p47phox primary anti-
body. The cells were rinsed, stained with a goat anti-rabbit Alexa Flour 594-
labeled secondary antibody, and counterstained with DAPI to identify the
nuclei. The number of cells exhibiting clustering was quantified from four inde-
pendent fields of view and expressed as the percent of the total population.480 Cell Metabolism 12, 467–482, November 3, 2010 ª2010 ElsevierAtherosclerotic Lesion Analysis
For morphometric lesion analysis, sections were stained with Harris’ hematox-
ylin and eosin (H&E). The total lesion area and necrotic area was quantified as
previously described (Seimon et al., 2009). For plaque necrosis, boundary lines
were drawn around regions that were free of H&E staining, and area measure-
ments were obtained using image analysis software (Seimon et al., 2009).
A 3000 mm2 threshold was implemented in order to avoid counting regions
that likely do not represent substantial areas of necrosis. Using this method,
a 97% agreement in the percent necrotic area was calculated between our
two independent observers.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Supplemental References, and three figures and can be found with this article
online at doi:10.1016/j.cmet.2010.09.010.
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